Total item
Cart Subtotal
$0.00 - Majid Momeny, .et al. Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells, Eur J Pharmacol, 2020, 882:173298
Biological Activity
Cediranib (AZD2171) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases.
Targets
| Target | Value |
|---|---|
| VEGFR2/KDR | IC50: 0.5nM |
| c-Kit | IC50: 2nM |
| VEGFR3/FLT4 | IC50: <=3nM |
| VEGFR1/FLT1 | IC50: 5nM |
| PDGFRβ | IC50: 5nM |
| FGFR1 | IC50: 26nM |
| PDGFRα | IC50: 36nM |
| CSF-1R | IC50: 110nM |
| Src | IC50: 130nM |
| Abl | IC50: 260nM |
| FLT3 | IC50: >1μM |
| HER2/ErbB2 | IC50: >1μM |
| CDK2 | IC50: >1μM |
| CDK4 | IC50: >1μM |
| EGFR | IC50: 1.6μM |
| AuroraA | IC50: >10μM |
| AuroraB | IC50: >10μM |
| MEK | IC50: >10μM |
| In vitro (25°C) | DMSO | 90 mg/mL (199.77 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
| In vivo | 0.5% methylcellulose | 30 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.2 mL | 110.99 mL | 221.98 mL |
| 0.5 mM | 4.44 mL | 22.2 mL | 44.4 mL |
| 1 mM | 2.22 mL | 11.1 mL | 22.2 mL |
| 5 mM | 0.44 mL | 2.22 mL | 4.44 mL |
*The above data is based on the productmolecular weight 450.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A10185 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 450.5 |
| Formula | C25H27FN4O3 |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 288383-20-0 |
| Synonyms | Recentin |
| SMILES | CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5 |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Raf265 derivative
Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.
SU 5416 (Semaxinib)
SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and …
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an ora…
Ki8751
Ki8751 is a cell-permeable quinolyloxyphenyl-urea compound that acts as a Flk-1 (VEGFR-2)-selective inhibitior in both cell-based and cell-f…
TG 100572
TG 100572 is VEGFR2 and Src kinase inhibitor.
Bibf1120 (Nintedanib)
BIBF1120 (Vargatef) is a novel triple angiokinase inhibitor that inhibits three growth factor receptors simultaneously: VEGFR, PDGF and FGFR…
Vatalanib (PTK787) 2HCl
Vatalanib (PTK787 or PTK/ZK) is a small molecule protein kinase inhibitor that inhibits angiogenesis that inhibits all known VEGF receptors,…
(-)-Catechin gallate
(-)-Catechin gallate is an antioxidant constituent of green tea. At uM concentrations, inhibits VEGF-induced tyrosine phosphorylation.
Keywords:buy Cediranib (AZD2171) | Cediranib (AZD2171) Supplier | purchase | cost | manufacturer | order | distributor | buy 288383-20-0| 288383-20-0 Supplier | purchase 288383-20-0 | 288383-20-0 cost | 288383-20-0 manufacturer | order 288383-20-0 | 288383-20-0 distributor
Adooq Quality Guarantee
We promise all products perform as described.